Literature DB >> 30617622

Two Prenatal Cases of Hyper-IgE Syndrome.

Makiko Egawa1, Kohsuke Imai2, Yoko Taketani3, Tomohiro Morio4, Naoyuki Miyasaka3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30617622     DOI： 10.1007/s10875-018-0588-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  7 in total

1.  Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.

Authors:  Yoshiyuki Minegishi; Masako Saito; Shigeru Tsuchiya; Ikuya Tsuge; Hidetoshi Takada; Toshiro Hara; Nobuaki Kawamura; Tadashi Ariga; Srdjan Pasic; Oliver Stojkovic; Ayse Metin; Hajime Karasuyama
Journal:  Nature       Date:  2007-08-05       Impact factor: 49.962

2.  Evolution of maternofetal transport of immunoglobulins during human pregnancy.

Authors:  A Malek; R Sager; P Kuhn; K H Nicolaides; H Schneider
Journal:  Am J Reprod Immunol       Date:  1996-11       Impact factor: 3.886

3.  The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study.

Authors:  A E Czeizel; M Rockenbauer; H T Sørensen; J Olsen
Journal:  Reprod Toxicol       Date:  2001 Nov-Dec       Impact factor: 3.143

4.  Multicolor Flow Cytometry for the Diagnosis of Primary Immunodeficiency Diseases.

Authors:  Takehiro Takashima; Miko Okamura; Tzu-Wen Yeh; Tsubasa Okano; Motoi Yamashita; Keisuke Tanaka; Akihiro Hoshino; Noriko Mitsuiki; Masatoshi Takagi; Eiichi Ishii; Kohsuke Imai; Hirokazu Kanegane; Tomohiro Morio
Journal:  J Clin Immunol       Date:  2017-06-08       Impact factor: 8.317

5.  Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.

Authors:  Marie-Olivia Chandesris; Isabelle Melki; Angels Natividad; Anne Puel; Claire Fieschi; Ling Yun; Caroline Thumerelle; Eric Oksenhendler; David Boutboul; Caroline Thomas; Cyrille Hoarau; Yvon Lebranchu; Jean-Louis Stephan; Celine Cazorla; Nathalie Aladjidi; Marguerite Micheau; François Tron; André Baruchel; Vincent Barlogis; Gilles Palenzuela; Catherine Mathey; Stéphane Dominique; Gérard Body; Martine Munzer; Fanny Fouyssac; Rolland Jaussaud; Brigitte Bader-Meunier; Nizar Mahlaoui; Stéphane Blanche; Marianne Debré; Muriel Le Bourgeois; Virginie Gandemer; Nathalie Lambert; Virginie Grandin; Stéphanie Ndaga; Corinne Jacques; Chantal Harre; Monique Forveille; Marie-Alexandra Alyanakian; Anne Durandy; Christine Bodemer; Felipe Suarez; Olivier Hermine; Olivier Lortholary; Jean-Laurent Casanova; Alain Fischer; Capucine Picard
Journal:  Medicine (Baltimore)       Date:  2012-07       Impact factor: 1.889

6.  Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.

Authors:  Joshua D Milner; Jason M Brenchley; Arian Laurence; Alexandra F Freeman; Brenna J Hill; Kevin M Elias; Yuka Kanno; Christine Spalding; Houda Z Elloumi; Michelle L Paulson; Joie Davis; Amy Hsu; Ava I Asher; John O'Shea; Steven M Holland; William E Paul; Daniel C Douek
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

7.  Coronary artery abnormalities in Hyper-IgE syndrome.

Authors:  Alexandra F Freeman; Elizabeth Mannino Avila; Pamela A Shaw; Joie Davis; Amy P Hsu; Pamela Welch; Jatin R Matta; Colleen Hadigan; Roderic I Pettigrew; Steven M Holland; Ahmed M Gharib
Journal:  J Clin Immunol       Date:  2011-04-15       Impact factor: 8.542
  7 in total
  1 in total

1.  Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance.

Authors:  Joëlle Khourieh; Peng Zhang; Franck Rapaport; Qian Zhang; Anne Puel; Vivien Béziat; Jean-Laurent Casanova; Bertrand Boisson; Takaki Asano; András N Spaan; Juan Li; Wei-Te Lei; Simon J Pelham; David Hum; Maya Chrabieh; Ji Eun Han; Antoine Guérin; Joseph Mackie; Sudhir Gupta; Biman Saikia; Jamila E I Baghdadi; Ilham Fadil; Aziz Bousfiha; Tanwir Habib; Nico Marr; Luckshman Ganeshanandan; Jane Peake; Luke Droney; Andrew Williams; Fatih Celmeli; Nevin Hatipoglu; Tayfun Ozcelik; Capucine Picard; Laurent Abel; Stuart G Tangye; Stéphanie Boisson-Dupuis
Journal:  J Exp Med       Date:  2021-06-17       Impact factor: 14.307
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.